Southwestern Internal Medicine Conference: Calcium Antagonists in the Treatment of Hypertension
- 1 September 1985
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 290 (3) , 118-133
- https://doi.org/10.1097/00000441-198509000-00008
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension.Circulation, 1984
- Diltiazem in the Treatment of Mild or Moderate Essential Hypertension. Comparison with Metoprolol in a Crossover Double‐Blind TrialThe Journal of Clinical Pharmacology, 1984
- Adverse Reactions to Calcium AntagonistsDrugs, 1983
- The effects of intravenous verapamil on hemodynamic status of patients with coronary artery disease receiving propranolol.Circulation, 1982
- The 24-hour ambulatory blood pressure profile with verapamil.Circulation, 1982
- Effect of Verapamil on Glucose Response to Glucagon during Intravenous Infusion of SomatostatinHormone and Metabolic Research, 1980
- Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension.Circulation, 1980
- Treatment of hypertension with nifedipine, a calcium antagonistic agent.Circulation, 1979
- Calcium kinetics in the aorta of spontaneously hypertensive ratsCardiovascular Research, 1977
- Hypotensive Action and Increased Plasma Renin Activity by Ca2+ Antagonist (Nifedipine) in Hypertensive PatientsJapanese Heart Journal, 1976